Predictors of red cell alloimmunization in Kurdish multi transfused patients with hemoglobinopathies in Iraq

Hemoglobin

Volumn 39, Issue 6, 2015, Pages 423-426

  Al Mousawi, Muqdad M N ^a   Al Allawi, Nasir A S ^b   Alnaqshabandi, Rubad ^c  

^a Duhok Health Directorate   (Iraq)

^b UNIVERSITY OF DUHOK   (Iraq)

^c UNIVERSITY OF BAGHDAD   (Iraq)

Author keywords

Alloimmunization; hemoglobinopathies; Iraq; sickle cell disease; thalassemia ( thal)

Indexed keywords

ALLOANTIBODY; AUTOANTIBODY; ERYTHROCYTE ANTIBODY; HEMOGLOBIN; RHESUS ANTIGEN; RHESUS C ANTIBODY; RHESUS D ANTIBODY; RHESUS E ANTIBODY; BLOOD GROUP ABO SYSTEM; BLOOD GROUP RHESUS SYSTEM;

ADOLESCENT; ADULT; ALLOIMMUNIZATION; ARTICLE; BETA THALASSEMIA; BLOOD GROUP ABO SYSTEM; BLOOD GROUP KELL SYSTEM; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CHILD; EARLY DIAGNOSIS; ERYTHROCYTE; ETHNICITY; FEMALE; HEMOGLOBINOPATHY; HUMAN; KURD (PEOPLE); MAJOR CLINICAL STUDY; MALE; RED CELL ALLOIMMUNIZATION; SICKLE CELL ANEMIA; SPLENECTOMY; ADVERSE EFFECTS; BLOOD GROUP RHESUS SYSTEM; HEMOGLOBINOPATHIES; IMMUNOLOGY; INFANT; IRAQ; PRESCHOOL CHILD; YOUNG ADULT;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; ADULT; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; ERYTHROCYTES; FEMALE; HEMOGLOBINOPATHIES; HUMANS; INFANT; IRAQ; ISOANTIBODIES; MALE; RH-HR BLOOD-GROUP SYSTEM; YOUNG ADULT;

EID: 84945466715     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.3109/03630269.2015.1077460     Document Type: Article

References (26)

1. Iheanyi EO. Practical Management of Haemoglobinopathies, 1st ed. Oxford, UK: Blackwell Publishing Ltd, 2004
2. Hamamy HA, Al-Allawi NA. Epidemiological profile of common haemoglobinopathies in Arab countries. J Community Genet. 2013; 4 (2): 147-167
3. Cappellini MD, Cohen A, Eleftheriou A, et al. Guidelines for the Clinical Management of Thalassaemia, 2nd ed. Nicosia, Cyprus: Thalassaemia International Federation, 2008
4. Smith-Whitley K, Thompson AA. Indications and complications of transfusions in sickle cell disease. Pediatr Blood Cancer. 2012; 59 (2): 358-364
5. Steinberg MH, Forget BG, Higgs DR, Weatherall DJ, Eds. Disorders of Hemoglobin Genetics, Pathophysiology, and Clinical Management, 2nd ed. New York, NY: Cambridge University Press, 2009
6. Chou ST, Liem RI, Thompson AA. Challenges of alloimmunization in patients with haemoglobinopathies. Br J Haematol. 2012; 159 (4): 394-404
7. Sirchia G, Zanella A, Parravicini A, et al. Red cell alloantibodies in thalassemia major. Results of an Italian cooperative study. Transfusion. 1985; 25 (2): 110-112
8. Olujohungbe A, Hambleton I, Stephens L, et al. Red cell antibodies in patients with homozygous sickle cell disease: A comparison of patients in Jamaica and the United Kingdom. Br J Haematol. 2001; 113 (3): 661-665
9. Singer ST, Wu V, Mignacca R, et al. Alloimmunization and erythrocyte auto-immunization in transfusion dependent thalassemia patients of predominantly Asian descent. Blood. 2000; 96 (10): 3369-3373
10. Ameen R, Al-Shemmari S, Al-Humood S, et al. RBC alloimmunization and autoimmunization among transfusion-dependent Arab thalassemia patients. Transfusion. 2003; 43 (11): 1604-1610
11. Thompson AA, Cunningham MJ, Singer ST, et al. Red cell alloimmunization in a diverse population of transfused patients with thalassaemia. Br J Haematol. 2011; 153 (1): 121-128
12. Noor Haslina MN, Ariffin N, Illuni Hayati I, Rosline H. Red cell immunization in multiply transfused Malay thalassemia patients. Southeast Asian J Trop Med Public Health. 2006; 37 (5): 1015-1020
13. Hussein E, Desooky N, Rihan A, Kamal A. Predictors of red cell alloimmunization in multitransfused Egyptian patients with β-thalassemia. Arch Pathol Lab Med. 2014; 138 (5): 684-688
14. Bauer MP, Wiersum-Osselton J, Schipperus M, et al. Clinical predictors of alloimmunization after red blood cell transfusion. Transfusion. 2007; 47 (11): 2066-2071
15. Aygun B, Padmanabhan S, Paley C, Chandrasekaran V. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion. 2002; 42 (1): 37-43
16. Sakhalkar V, Roberts K, Hawthorne L, et al. Allosensitization in patients receiving multiple blood transfusions. Ann N Y Acad Sci. 2005; 1054: 494-499
17. Pahuja S, Pujani M, Gupta SK, et al. Alloimmunization and red cell autoimmunization in multitransfused thalassemics of Indian origin. Hematology. 2010; 15 (3): 174-177
18. Karimi M, Nikrooz P, Kashef S, et al. RBC alloimmunization in blood transfusion-dependent β-thalassemia patients in southern Iran. Int J Lab Hematol. 2007; 29 (5): 321-326
19. Hundrić-Haspl Z, Juraković-Loncar N, Grgicević D, Balija M. Alloimmunizations following blood transfusion. Acta Med Croatica. 1994; 48 (4-5): 193-197
20. Murao M, Viana MB. Risk factors for alloimmunization by patients with sickle cell disease. Braz J Med Biol Res. 2005; 38 (5): 675-682
21. Moreira G, Bordin JO, Kuroda A, Kerbauy J. Red blood cell alloimmunization in sickle cell disease: The influence of racial and antigenic pattern differences between donors and recipients in Brazil. Am J Hematol. 1996; 52 (3): 197-200
22. Shukla JS, Chaudhary RK. Red cell alloimmunization in multi-transfused chronic renal failure patients undergoing hemodialysis. Indian J Pathol Microbiol. 1999; 42 (3): 299-302
23. Rosse WF, Gallagher D, Kinney TR. Transfusion and alloimmunization in sickle cell disease. Blood. 1990; 76 (7): 1431-1437
24. Spanos T, Karageorga M, Ladis V, et al. Red cell alloantibodies in patients with thalassemia. Vox Sang. 1990; 58 (1): 50-55
25. Sadeghian MH, Keramati MR, Badiei Z, et al. Alloimmunization among transfusion-dependent thalassemia patients. Asian J Trans Sci. 2009; 3 (2): 95-98
26. Chao Y-H, Wu K-H, Lu J-J, et al. Red blood cell alloimmunization among Chinese patients with β-thalassaemia major in Taiwan. Blood Transfus. 2013; 11 (1): 71-74